Evid Based Nurs 12:45 doi:10.1136/ebn.12.2.45
  • Treatment

Review: weight-reducing agents improve glycaemic control and reduce progression to diabetes

S Czernichow

Dr S Czernichow, Unite de Recherche en Nutrition Humaine, Bobigny, France;


How do weight-reducing agents affect glycaemic parameters and risk of type 2 diabetes in predisposed individuals?


Included studies were randomised, double-blind, placebo controlled trials (RCTs) that evaluated the effects of weight-reducing agents (eg, orlistat, sibutramine, and rimonabant) on fasting glucose or glycated haemoglobin (HbA1c) concentrations and had a duration of ⩾1 year. Studies of mixed populations were excluded. Outcomes included weight loss, fasting glucose and HbA1c concentrations, and diabetes.


Medline was searched from …

No Related Web Pages

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article